Cankatan Gida Sanayi Ve Ticaretlim

2 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• UNAPPROVED1 refused line

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

Questions about Cankatan Gida Sanayi Ve Ticaretlim

Is Cankatan Gida Sanayi Ve Ticaretlim on an FDA import alert?

Yes. As of October 26, 2026, Cankatan Gida Sanayi Ve Ticaretlim is on the red list of FDA Import Alert 54-16, “Foods/supplements with active pharmaceutical ingredient”, for mplus epimediumlu bitkisel macun herbal paste with epimedium; FDA published the listing on April 14, 2023.

Has FDA refused shipments from Cankatan Gida Sanayi Ve Ticaretlim?

Yes. FDA refused 1 shipment line from Cankatan Gida Sanayi Ve Ticaretlim on October 28, 2022. The most recent, on October 28, 2022, was royal jelly (vit/min/protein/unconventional dietary spec for human/animal, n.e.c.), charged as UNAPPROVED (unapproved new drug).

Why did FDA refuse Cankatan Gida Sanayi Ve Ticaretlim's shipments?

The most frequent charge is UNAPPROVED (unapproved new drug, 1 line).

What is Cankatan Gida Sanayi Ve Ticaretlim's FEI number?

Cankatan Gida Sanayi Ve Ticaretlim's FDA Establishment Identifier (FEI) is 3023954122.

Can shipments from Cankatan Gida Sanayi Ve Ticaretlim still enter the U.S.?

Shipments of mplus epimediumlu bitkisel macun herbal paste with epimedium from Cankatan Gida Sanayi Ve Ticaretlim can be detained without physical examination under Import Alert 54-16; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).